http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011154579-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33faa2101ae06d662c670247216bda0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84ce950696faf2050139236adb317727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_edc2d12732a53e263eb5a4f8a020283e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a04728c750fdb47adf4db3a86b19323 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2011-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e7f6fbe296031f8d0069fc7ac494b3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d86d72344f86022a4a169dfbadcac8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a89b26f09abee4c7fc4cbee8a2d4a7 |
| publicationDate | 2011-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2011154579-A1 |
| titleOfInvention | In vitro diagnostic method for patients with splenic marginal zone lymphoma |
| abstract | The present invention describes an in vitro SMZL diagnostic method based on analysis of the expression of a series of genes located in a very specific deleted region of human chromosome 7. The deleted region in SMZL patients has been defined by means of high-resolution array CGH and is located at 7q22.1 between bases 99925039-101754718, preferably between 99925039-101348479, and more preferably between 100260234-100596921 and/or 101244026-101754718, which is the location for the following genes: CUX1, SH2B2, EPHB4, SLC12A9, TRIP6, SRRT, ACHE, UFSP1, TRIM56, SERPINE1, APIS1, VGF, TSC22D4, HRBL, LRCH4, MUC3, MUC12 and MUC17 . The present invention further describes in vitro SMZL diagnostic kits that comprise at least one probe that recognizes the deleted region at 7q22.1 or hybridizes with at least one of the nucleotide sequences of the genes mentioned above. |
| priorityDate | 2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.